Show
Sort by
-
- Journal Article
- A1
- open access
Developing and evaluating a participatory arts programme for cancer patients and their caregivers
-
- Journal Article
- A2
- open access
Acupuncture as a complementary therapy for cancer care : acceptability and preferences of patients and informal caregivers
-
Boerhaave's syndrome : successful conservative treatment in two patients
-
- Journal Article
- A1
- open access
Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials : a case-control study
-
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study
-
An observational pilot study to evaluate the feasibility and quality of (partial) oncological home-hospitalization
-
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib
-
The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment
-
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)
-
Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment
-
The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients
-
Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
-
Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
-
Preoperative chemosensitivity testing as predictor of adjuvant benefit in stage III colon
-
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology